Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9801–9850 of 33511
Departure of Charles Prow as President, Chief Executive Officer On May 9, 2024, Mr. Prow was separated as President and CEO of the Company, effective June 17, 2024.
each of Mr. Flesher, Mr.Dorenbaum, and Ms. Hall are expected to resign as executive officers of Reneo.
each of Mr. Flesher, Mr.Dorenbaum, and Ms. Hall are expected to resign as executive officers of Reneo.
each of Mr. Flesher, Mr.Dorenbaum, and Ms. Hall are expected to resign as executive officers of Reneo.
James C. Foster, Adam Gerchen, Todd P. Headley, Paul Hooper, Thomas F. Kelly, Samskriti King, Teresa H. Shea, and Barbara Stewart each resigned from the Board and from any and all committees of the Board on which they served and ceased to be directors of the Company.
James C. Foster, Adam Gerchen, Todd P. Headley, Paul Hooper, Thomas F. Kelly, Samskriti King, Teresa H. Shea, and Barbara Stewart each resigned from the Board and from any and all committees of the Board on which they served and ceased to be directors of the Company.
James C. Foster, Adam Gerchen, Todd P. Headley, Paul Hooper, Thomas F. Kelly, Samskriti King, Teresa H. Shea, and Barbara Stewart each resigned from the Board and from any and all committees of the Board on which they served and ceased to be directors of the Company.
James C. Foster, Adam Gerchen, Todd P. Headley, Paul Hooper, Thomas F. Kelly, Samskriti King, Teresa H. Shea, and Barbara Stewart each resigned from the Board and from any and all committees of the Board on which they served and ceased to be directors of the Company.
Immediately following the Effective Time, Brian Sheth and Ian Loring ceased to be directors of the Company
James C. Foster, Adam Gerchen, Todd P. Headley, Paul Hooper, Thomas F. Kelly, Samskriti King, Teresa H. Shea, and Barbara Stewart each resigned from the Board and from any and all committees of the Board on which they served and ceased to be directors of the Company.
James C. Foster, Adam Gerchen, Todd P. Headley, Paul Hooper, Thomas F. Kelly, Samskriti King, Teresa H. Shea, and Barbara Stewart each resigned from the Board and from any and all committees of the Board on which they served and ceased to be directors of the Company.
James C. Foster, Adam Gerchen, Todd P. Headley, Paul Hooper, Thomas F. Kelly, Samskriti King, Teresa H. Shea, and Barbara Stewart each resigned from the Board and from any and all committees of the Board on which they served and ceased to be directors of the Company.
James C. Foster, Adam Gerchen, Todd P. Headley, Paul Hooper, Thomas F. Kelly, Samskriti King, Teresa H. Shea, and Barbara Stewart each resigned from the Board and from any and all committees of the Board on which they served and ceased to be directors of the Company.
Immediately following the Effective Time, Brian Sheth and Ian Loring ceased to be directors of the Company
Max J. Levy resigned from the Board, effective June 1, 2024.
On May 8, 2024, Mimi Flanagan, the Chief Financial Officer and Treasurer of the Company, notified the Company that she will be resigning from her positions effective May 20, 2024.
On May 8, 2024, R. Kerry Clark informed the Company that he has decided not to stand for reelection to the Board of Directors at the Company’s 2024 Annual Meeting of Shareholders in September.
On May 10, 2024, David Silberman, the Chief Financial Officer, Treasurer and Secretary (the “CFO”) of Oramed Pharmaceuticals Inc. (the “Company”), resigned from his positions with the Company for personal reasons, effective as of July 12, 2024.
James D. Hiza, our President and the sole member of the board of directors (the “Board”) of the Company, resigned from those positions
In addition, at the Second Merger Effective Time, Scott A. Cox, Chief Executive Officer, ceased serving in such positions.
Director Richard W. Kramp passed away on May 2, 2024.
On May 10, 2024 (the “Effective Date”), Zachary B. Fleming delivered notice to the Board of Directors of the Company (the “Board”) that he is resigning from his position as Chief Executive Officer of the Company, effective immediately.
On May 13, 2024, Unity Software Inc. (the “ Company ”) announced that Marc Whitten will resign as the Company’s Chief Product and Technology Officer, Create, effective as of June 1, 2024
On May 6, 2024, Gina Corradetti provided Accuray Incorporated (the “Company”) with notice of her intent to resign from her position as VP, Chief Accounting Officer and principal accounting officer, which resignation will be effective May 17, 2024, to pursue other opportunities.
Effective March 31, 2024, F. Gregory Guerra resigned as a director of Cincinnati Bell Inc. (the “Company”) .
On May 8, 2024, Sailaja Puttagunta M.D. notified Iterum Therapeutics plc (the “Company”) of her decision to resign as Chief Medical Officer the Company, effective May 31, 2024.
announced that Joseph Ciaffoni will step down as the President and Chief Executive Officer of Collegium Pharmaceutical, Inc. (the “Company”) effective May 24, 2024.
Ondrej Vlcek will transition from Gen and depart from his role as President
On May 8, 2024, John Doyle informed BlackRock Direct Lending Corp. (the “Company”) of his intention to resign from the Board of Directors of the Company and from his positions as President and Chief Operating Officer of the Company, effective immediately.
On May 10, 2024, Patterson Companies, Inc. (the “Company”) announced that Tim E. Rogan, who has served as President of Patterson Dental since July 2021, has stepped down from his role, effective immediately
On May 8, 2024, Dr. Dov S. Zakheim tendered, and the Board of Directors (the “Board”) of TTM Technologies, Inc. (the “Company”) accepted, his resignation from his position as a Class I director of the Company and any Board committees thereof.
On April 1, 2024, the Company issued a press release announcing Claudia Jaramillo’s departure from the Company and Kevin Berryman’s appointment as the Company’s interim Chief Financial Officer.
At the completion of the Transaction, effective May 6, 2024, Mr. John M. Howard departed from the Company to continue serving as Chief Executive Officer of Truist Insurance.
On May 10, 2024, Mr. Anthony Geisler, Chief Executive Officer and Director of Xponential Fitness, Inc. (the “Company”), was removed by the Company’s Board of Directors from his duties and suspended indefinitely as Chief Executive Officer.
On May 6, 2024, Jeffrey Pfeffer gave notice of his resignation from the Board of Directors (the “Board”) of Longeveron Inc. (the “Company”) and from each committee of the Board, to be effective immediately.
On May 8, 2024, Cathy Ross gave notice of her resignation from the Board and from each committee of the Board, to be effective immediately.
Ms. Shirley Cheng, the Chief Financial Officer, Corporate Secretary and Director of Network CN Inc. (the “Company”) notified the Company of her intention to resign from her position for personal reasons. Ms. Cheng’s resignation will become effective on May 12, 2024.
On May 6, 2024, R.H. Seale, III provided notice to Q2 Holdings, Inc. (" Q2 ") of his decision not to stand for re-election to the Board of Directors of Q2 (the " Board ").
On May 6, 2024, A. Allen Arroyo, Chief Financial Officer, principal financial officer and principal accounting officer of Rocky Mountain Chocolate Factory, Inc. (the “Company”), notified the Company of his intention to resign effective May 17, 2024.
On May 7, 2024, Kevin Mullins notified Wrap Technologies, Inc. (the “Company”) of his intention to resign from his position as President of the Company, effective May 23, 2024.
the Board appointed Chunyang Liu, Lidong Wang and Wenfang Lu to fill vacancies on the Company’s Board of Directors caused by the resignation of Ms. Xiaowei Jin
Pursuant to the terms of the Letter Agreement dated September 27,2023, Scott White departed the Company as the Chief Operating Officer on May 3, 2024.
On May 7, 2024, Jeffrey A. Doctoroff, Executive Vice President, General Counsel and Corporate Secretary of MultiPlan Corporation (“MultiPlan” or the “Company”), provided the Company with notice of his resignation, effective on or about June 30, 2024.
On May 9, 2024, A. O. Smith Corporation (the “Company”) announced that Mark Petrarca, Senior Vice President - Human Resources and Public Affairs, will retire effective August 1, 2024.
On May 7, 2024, Andrew Makrides announced his retirement as a director and Chairman of the Board, effective on the same date.
Mr. Lehberger, age 51, will succeed Brock Albinson, who will be stepping down from this role as of June 30, 2024.
On May 6, 2024, Danish Qureshi, the President and Chief Operating Officer of LifeStance Health Group, notified the Company of his decision to depart the Company, effective June 30, 2024.
On May 9, 2024 (the "Effective Date"), Entravision Communications Corporation (the “Company”) terminated the employment of Christopher T. Young, Chief Financial Officer, and Juan Saldívar von Wuthenau, Chief Strategy and Business Development Officer, each effective immediately.
On May 9, 2024 (the "Effective Date"), Entravision Communications Corporation (the “Company”) terminated the employment of Christopher T. Young, Chief Financial Officer, and Juan Saldívar von Wuthenau, Chief Strategy and Business Development Officer, each effective immediately.
Dr. Gavriel “Gaby” Hayon, Executive Vice President of Research & Development of Mobileye Global Inc. (the “Company”) notified the Company of his decision to retire after 25 years with the Company and to step down from his role as Executive Vice President of Research & Development by the end of 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.